关注
Mohammad Mahmoudian
Mohammad Mahmoudian
Candiolo Cancer Institute - FPO - IRCCS, University of Turin,Italy
在 ircc.it 的电子邮件经过验证
标题
引用次数
引用次数
年份
Bortezomib-loaded solid lipid nanoparticles: preparation, characterization, and intestinal permeability investigation
M Mahmoudian, H Valizadeh, P Zakeri-Milani
Drug development and industrial pharmacy 44 (10), 1598-1605, 2018
362018
Stabilization and anticancer enhancing activity of the peptide nisin by cyclodextrin-based nanosponges against colon and breast cancer cells
Y Khazaei Monfared, M Mahmoudian, C Cecone, F Caldera, ...
Polymers 14 (3), 594, 2022
342022
Natural low-and high-density lipoproteins as mighty bio-nanocarriers for anticancer drug delivery
M Mahmoudian, S Salatin, AY Khosroushahi
Cancer chemotherapy and pharmacology 82, 371-382, 2018
332018
Preparation and characterization of cyclodextrin nanosponges for bortezomib delivery
S Allahyari, H Valizadeh, L Roshangar, M Mahmoudian, F Trotta, ...
Expert Opinion on Drug Delivery 17 (12), 1807-1816, 2020
312020
Safety and toxicity issues of therapeutically used nanoparticles from the oral route
F Lotfipour, S Shahi, A Farjami, S Salatin, M Mahmoudian, SM Dizaj
BioMed Research International 2021 (1), 9322282, 2021
202021
Enhancement of the intestinal absorption of bortezomib by self-nanoemulsifying drug delivery system
M Mahmoudian, H Valizadeh, R Löbenberg, P Zakeri-Milani
Pharmaceutical development and technology 25 (3), 351-358, 2020
192020
Nisin delivery by nanosponges increases its anticancer activity against in-vivo melanoma model
YK Monfared, M Mahmoudian, F Caldera, AR Pedrazzo, P Zakeri-Milani, ...
Journal of Drug Delivery Science and Technology 79, 104065, 2023
122023
Oral delivery of solid lipid nanoparticles: Underlining the physicochemical characteristics and physiological condition affecting the lipolysis rate
M Mahmoudian, S Maleki Dizaj, S Salatin, R Löbenberg, M Saadat, ...
Expert Opinion on Drug Delivery 18 (11), 1707-1722, 2021
122021
Bortezomib-loaded lipidic-nano drug delivery systems; formulation, therapeutic efficacy, and pharmacokinetics
M Mahmoudian, H Valizadeh, R Löbenberg, P Zakeri-Milani
Journal of microencapsulation 38 (3), 192-202, 2021
102021
Self-assembled peptide nanoparticles for efficient delivery of methotrexate into cancer cells
P Zakeri-Milani, A Shirani, A Nokhodchi, S Mussa Farkhani, ...
Drug Development and Industrial Pharmacy 46 (4), 521-530, 2020
102020
Investigating intestinal permeability of bortezomib using a validated HPLC-UV method
M Mahmoudian, P Zakeri-Milani, H Valizadeh
Drug research 69 (03), 130-135, 2019
102019
Cyclodextrin-Based Nanosponges as Perse Antimicrobial Agents Increase the Activity of Natural Antimicrobial Peptide Nisin
Y Khazaei Monfared, M Mahmoudian, G Hoti, F Caldera, ...
Pharmaceutics 14 (3), 685, 2022
92022
Oral supplementation of solvent-free kynurenic acid/cyclodextrin nanosponges complexes increased its bioavailability
YK Monfared, AR Pedrazzo, M Mahmoudian, F Caldera, P Zakeri-Milani, ...
Colloids and Surfaces B: Biointerfaces 222, 113101, 2023
82023
Synthesis and preparation of vitamin A coupled butein-loaded solid lipid nanoparticles for liver fibrosis therapy in rats
S Mahdinloo, S Hemmati, H Valizadeh, M Mahmoudian, J Mahmoudi, ...
International Journal of Pharmaceutics 625, 122063, 2022
82022
Surface modification with cholesteryl acetyl carnitine, a novel cationic agent, elevates cancer cell uptake of the PEGylated liposomes
F Zahednezhad, JS Mojarrad, P Zakeri-Milani, B Baradaran, ...
International Journal of Pharmaceutics 609, 121148, 2021
82021
The Factors Determining the Skin Penetration and Cellular Uptake of Nanocarriers: New Hope for Clinical Development
A Farjami, S Salatin, S Jafari, M Mahmoudian, M Jelvehgari
Current pharmaceutical design 27 (42), 4315-4329, 2021
82021
Hyper-branched cationic cyclodextrin polymers for improving plasmid transfection in 2D and 3D spheroid cells
YK Monfared, M Mahmoudian, C Cecone, F Caldera, S Haiaty, ...
Pharmaceutics 14 (12), 2690, 2022
72022
The therapeutic benefits of intravenously administrated nanoparticles in stroke and age-related neurodegenerative diseases
M Farhoudi, S Sadigh-Eteghad, J Mahmoudi, A Farjami, M Mahmoudian, ...
Current Pharmaceutical Design 28 (24), 1985-2000, 2022
62022
Enhanced intracellular accumulation and cytotoxicity of bortezomib against liver cancer cells using N-stearyl lactobionamide surface modified solid lipid nanoparticles
F Mostafaei, S Hemmati, H Valizadeh, M Mahmoudian, M Sarfraz, M Abdi, ...
International Journal of Pharmaceutics 649, 123635, 2024
32024
Acetyl carnitine modified liposomes elevate cisplatin uptake in macrophage and cancer cells
F Zahednezhad, P Zakeri-Milani, JS Mojarrad, M Sarfraz, M Mahmoudian, ...
Journal of Drug Delivery Science and Technology 81, 104198, 2023
32023
系统目前无法执行此操作,请稍后再试。
文章 1–20